K Number
K043138
Device Name
PROVOX NID VOICE REHABILITATION SYSTEM, MODEL REF 7101 TO 7134
Manufacturer
Date Cleared
2004-11-22

(10 days)

Product Code
Regulation Number
874.3730
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Provox® NID™ Voice Rehabilitation System is intended for use in prosthetic voice rehabilitation after total laryngectomy only by patients who have been trained in the use of the device and, as assessed by the clinician who prescribes the device, have demonstrated the ability to understand and consistently follow the Instructions for Use without clinician supervision. The Provox NID is intended for single patient use.
Device Description
The Provox® NID™ Rehabilitation System is a non-indwelling (Standard) voice prosthesis equipped with a safety medallion, an insertion tool and some accessories. The Provox NID voice prosthesis is available in two outer diameters (17 and 20 French) and six different lengths, (6, 8, 10, 12, 14 and 18 mm). Each prosthesis comes individually packed with a re-usable inserter. The design of the device is based on the indwelling voice prostheses Provox1, Provox2 and ActiValve.
More Information

Not Found

No
The summary describes a mechanical voice prosthesis and its accessories. There is no mention of software, algorithms, or any technology that would typically incorporate AI/ML.

Yes
The device is described as a "Voice Rehabilitation System" intended for "prosthetic voice rehabilitation after total laryngectomy," indicating its use in restoring or improving a physiological function.

No

Explanation: The device is described as a voice prosthesis used for rehabilitation after total laryngectomy, not for diagnosing a condition. Its purpose is to facilitate prosthetic voice, which is a therapeutic function.

No

The device description explicitly states it is a "non-indwelling (Standard) voice prosthesis equipped with a safety medallion, an insertion tool and some accessories," and mentions different sizes and a re-usable inserter, indicating it is a physical medical device with hardware components.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is for "prosthetic voice rehabilitation after total laryngectomy." This is a therapeutic and rehabilitative purpose, not a diagnostic one.
  • Device Description: The device is a "non-indwelling (Standard) voice prosthesis." This is a physical device used to facilitate speech, not to perform tests on biological samples.
  • Lack of IVD Characteristics: The description does not mention any of the typical characteristics of an IVD, such as:
    • Analyzing biological samples (blood, urine, tissue, etc.)
    • Providing information about a patient's health status, disease, or condition based on in vitro testing.
    • Using reagents or assays.

The device is a medical device used for rehabilitation, not for in vitro diagnostic testing.

N/A

Intended Use / Indications for Use

The Provox® NID™ Voice Rehabilitation System is intended for use in prosthetic voice rehabilitation after total laryngectomy only by patients who have been trained in the use of the device and, as assessed by the clinician who prescribes the device, have demonstrated the ability to understand and consistently follow the Instructions for Use without clinician supervision.

The Provox NID is intended for single patient use.

Product codes

EWL

Device Description

The Provox® NID™ Rehabilitation System is a non-indwelling (Standard) voice prosthesis equipped with a safety medallion, an insertion tool and some the accessories.

The Provox NID voice prosthesis is available in two outer diameters (17 and 20 French) and six different lengths, (6, 8, 10, 12, 14 and 18 mm). Each prosthesis comes individually packed with a re-usable inserter. The design of the device is based on the indwelling voice prostheses Provox1, Provox2 and ActiValve.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

only by patients who have been trained in the use of the device and, as assessed by the clinician who prescribes the device, have demonstrated the ability to understand and consistently follow the Instructions for Use without clinician supervision.

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Performed by Princess Alexandra Hospital, Brisbane, Australia. The Human Clinical Test Research Ethics Committee of the hospital approved the study. All of the patients were using the Blom-Singer Low Pressure Voice Prosthesis prior to this study. In total, 14 patients participated in this clinical trail.

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Test results support the conclusion that the actual device performance satisfies the design intent. Functional equivalency test have been performed on the three prostheses, which demonstrate the equivalency of the valve performance with the three designs.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K971244, K821568

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 874.3730 Laryngeal prosthesis (Taub design).

(a)
Identification. A laryngeal prosthesis (Taub design) is a device intended to direct pulmonary air flow to the pharynx in the absence of the larynx, thereby permitting esophageal speech. The device is interposed between openings in the trachea and the esophagus and may be removed and replaced each day by the patient. During phonation, air from the lungs is directed to flow through the device and over the esophageal mucosa to provide a sound source that is articulated as speech.(b)
Classification. Class II (special controls). The device, when it is a voice amplification device, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 874.9.

0

Image /page/0/Picture/1 description: The image shows the text "Premarket Notification 510(k) Provox® NID™ Voice Rehabilitation System". The text is left-aligned and appears to be the title or heading of a document. The text is written in a simple, sans-serif font and is easy to read.

Image /page/0/Picture/2 description: The image shows the logo for Atos Medical. The word "ATOS" is in large, bold, black letters. Below the word "ATOS" is a black line, and below the line is the word "MEDICAL" in a smaller font.

Page 1 of 3

6.4 510(k) Summary of Safety and Effectiveness

DateMonday, November 08, 2004
510(k) NumberK043138 (To be assigned)
Submitter's NameAtos Medical AB
P O Box 183
Kraftgatan 8
SE-242 22 Hörby
Sweden
Telephone: Int+46-415-198 00
Fax: Int+46-415-198 98
E-mail: info@atosmedical.com
Contact PersonEddy Åberg
Director of Quality & Regulatory Affairs
Trade or Proprietary NameProvox® NID™ Voice Rehabilitation System
Common or Usual NameVoice Prosthesis
Device Classification NameLaryngeal prosthesis (Taub design)
Product CodeEWL

1

Image /page/1/Picture/0 description: The image shows the text "Premarket Notification 510(k) Provox® NID™ Voice Rehabilitation System". The text is arranged in three lines, with the first line indicating the type of notification, the second line indicating the brand name, and the third line indicating the purpose of the system. The text is written in a clear and legible font.

Image /page/1/Picture/1 description: The image shows the logo for Atos Medical. The word "ATOS" is in large, bold, sans-serif font. Below the word "ATOS" is a horizontal line, and below the line is the word "MEDICAL" in a smaller, sans-serif font.

Page 2 of 3

| Predicate

DevicesProvox®2 Voice Prosthesis System
510(k) Number : K971244
Atos Medical AB, Sweden
Blom-Singer Low Pressure Voice Prosthesis
510(k) Number: K821568
Inhealth Technologies, USA
  • The Provox NID voice rehabilitation system is intended for use in prosthetic voice Intended Use rehabilitation after total laryngectomy only by patients who have been trained in the use of the device and, as assessed by the clinician who prescribes the device, have demonstrated the ability to understand and consistently follow the Instructions for Use without clinician supervision.
    The Provox NID is intended for single patient use.

The Provox® NID™ Rehabilitation System is a non-indwelling (Standard) voice Description of prosthesis equipped with a safety medallion, an insertion tool and some the Device accessories.

Image /page/1/Picture/7 description: The image shows two medical instruments. The first instrument is a laryngoscope, which is used to view the larynx. It has a handle and a blade with a light at the end. The second instrument is a tracheostomy tube holder, which is used to secure a tracheostomy tube in place. The holder has a strap that goes around the neck and a clamp that attaches to the tube.

The Provox NID voice prosthesis is available in two outer diameters (17 and 20 French) and six different lengths, (6, 8, 10, 12, 14 and 18 mm). Each prosthesis

2

Image /page/2/Picture/0 description: The image shows the logo for Atos Medical. The word "ATOS" is in large, bold, sans-serif font, with a thick line underneath. Below the line, the word "MEDICAL" is printed in a smaller, sans-serif font.

Page 3 of 3 comes individually packed with a re-usable inserter. The design of the device is based on the indwelling voice prostheses Provox1, Provox2 and ActiValve. Performed by Princess Alexandra Hospital, Brisbane, Australia. The Human Clinical Test Research Ethics Committee of the hospital approved the study. All of the patients were using the Blom-Singer Low Pressure Voice Prosthesis prior to this study. In total, 14 patients participated in this clinical trail. Test results support the conclusion that the actual device performance satisfies the design intent. The proposed device is substantially equivalent to the legally marketed predicate Technological Characteristics devices in design, intended use and materials of manufacturer. The Provox® NID™ Rehabilitation System is provided for the same indications for use as its predicate devices, the Provox®2 Voice Prosthesis System and the Blom-Singer Low Pressure Voice Prosthesis. All three devices are designed to provide voicing after total laryngectomy. The devices are placed in a surgically created fistula between the trachea and esophagus in order to divert air through the

prosthesis valve to created voicing.

Functional equivalency test have been performed on the three prostheses, which demonstrate the equivalency of the valve performance with the three designs.

3

Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is an abstract symbol resembling an eagle or bird in flight, composed of three curved lines.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

NOV 2 2 2004

Atos Medical AB Attn: Eddy Åberg P O Box 183 Kraftgatan 8 SE-242 22 Hörby Sweden

Re: K043138

: 11015150
Trade/Device Name: Provox® NID™ Voice Rehabilitation System Regulation Number: 21 CFR 874.3730 Regulation Name: Laryngeal Prosthesis (Taub design) Regulatory Class: II Product Code: EWL Dated: November 8, 2004 Received: November 12, 2004

Dear Ms. Åberg:

We have reviewed your Section 510(k) premarket notification of intent to market the device we nave rothered your because in the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce ass baced in 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic mat (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be fray of the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

4

Page 2 - Ms. Åberg

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4613. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

A kalpi korenthal

A. Ralph Rosenthal, M.D Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

5

Image /page/5/Picture/1 description: The image shows the logo for ATOS MEDICAL. The word "ATOS" is in large, bold, sans-serif font. A horizontal line is directly below the word "ATOS", and the word "MEDICAL" is below the line. The word "MEDICAL" is in a smaller, sans-serif font.

6.3 Indications for Use

Applicant:Atos Medical AB, Sweden
510(k) Number:K043138(To be assigned)
Device Name:Provox® NID™ Voice Rehabilitation System

Intended Use:

The Provox® NID™ Voice Rehabilitation System is intended for use in prosthetic voice rehabilitation after total laryngectomy only by patients who have been trained in the use of the device and, as assessed by the clinician who prescribes the device, have demonstrated the ability to understand and consistently follow the Instructions for Use without clinician supervision.

The Provox NID is intended for single patient use.

PLEASE DO NOT WRITE BELOW THIS LINE CONTINUE ON ANOTHER PAGE IF NEEDED

Concurrence of CDRH, Office of Device Evaluation

Prescription Use

or

(Per 21 CFR 801.109)

Over-the-counter

(Division Sign-Off) Division of Onhthalmic Ear, Nose and Throat Davises

510(k) Number: K043138

6-13

Phone +46 415 198 00 Fax +46 415 198 98 E-mail info@atosmedical.com Web www.atosmedical.com

Org. nr. 556268-7607 Vat No. SE556268760701